![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 15, 11478-11483, April 14, 2000
From the Centre for Thrombosis and Vascular Research, The
University of New South Wales, and Department of Haematology,
Prince of Wales Hospital, Sydney, Australia
Platelet-derived growth factor (PDGF), which
consists of an A and/or B chain, stimulates migration and proliferation
in vascular smooth muscle cells as well as a large number of other cell
types. Investigations over recent years have defined roles for several positive regulatory transcription factors in the PDGF-B promoter. However, little is known about the transcriptional mechanisms that
negatively regulate this gene. Here, we used transient transfection and
5' deletion analysis to define a specific region in the PDGF-B promoter-mediating repression in vascular smooth muscle cells. Gel retardation assays revealed this region is bound by nuclear protein(s) in a specific manner. Supershift assays excluded the direct
association of Sp1, Sp3, and Egr-1. Mutation of the negative regulatory
element no longer supported nucleoprotein complex formation and, when
introduced into the PDGF-B promoter, rescued the promoter from
repression. Promoter activity was also restored by transfection of
oligonucleotide decoys bearing the repressor binding site. The
MEK1/2 inhibitor, PD98059, and a dominant negative construct generating
inactive ERK1 increased reporter expression driven by the PDGF-B
promoter. In contrast, the MEK inhibitor had no effect on the activity
of the mutant PDGF-B promoter. These effects were cell type-specific,
since neither suppression of the PDGF-B promoter nor nucleoprotein
complex formation was observed in vascular endothelial cells. These
findings define a distinct negative regulatory element in the PDGF-B
promoter that interacts with nuclear protein(s) and inhibits PDGF-B
promoter-dependent gene expression in an
ERK-dependent manner.
Novel Negative Regulatory Element in the Platelet-derived Growth
Factor B Chain Promoter That Mediates ERK-dependent
Transcriptional Repression*
and
*
This work was supported by grants from the National Heart
Foundation, National Health and Medical Research Council and New South
Wales Department of Health.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a Australian Postgraduate Research Award.
§
Supported by a Research Fellowship from the National Health and
Medical Research Council of Australia. To whom correspondence should be
addressed: Centre for Thrombosis and Vascular Research, School of
Pathology, The University of New South Wales, Sydney, NSW 2052, Australia. Tel.: 61-2-9385 2537; Fax: 61-2-9385 1389; E-mail: L. Khachigian@unsw.edu.au.
This article has been cited by other articles:
![]() |
M. P. Allen, M. Xu, D. A. Linseman, J. E. Pawlowski, G. M. Bokoch, K. A. Heidenreich, and M. E. Wierman Adhesion-related Kinase Repression of Gonadotropin-releasing Hormone Gene Expression Requires Rac Activation of the Extracellular Signal-regulated Kinase Pathway J. Biol. Chem., October 4, 2002; 277(41): 38133 - 38140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |